Placeholder Banner

BIO Signs Coalition Letter In Support of the IGNITE American Innovation Act

August 5, 2020

We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated through a focus on researching and producing products and technologies that create long-term value. Your legislation is by far the most significant proposal under consideration to provide liquidity to startups and sustain critical economic activity that will pay long-term dividends to American workers and the economy. We commend your strong leadership during this crisis and look forward to working with you to include the IGNITE American Innovation Act in an upcoming economic recovery package.

Download Full Comments Below
BIO Signs Coalition Letter In Support of the IGNITE American Innovation Act
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.
BIO submitted general comments and proposed changes to FDA (Docket No. FDA-2023-D-0026)